188Re(CO)3-dipicolylamine-alendronate: A new bisphosphonate conjugate for the radiotherapy of bone metastases

Bioconjugate Chemistry

Volumn 21, Issue 5, 2010, Pages 811-815

  Torres Martin De Rosales, Rafael ^a   Finucane, Ciara ^b   Foster, Julie ^b   Mather, Stephen J ^b   Blower, Philip J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BONE;

ALENDRONATE; BI-FUNCTIONAL; BISPHOSPHONATES; BONE METASTASIS; EFFICIENT SYNTHESIS; HIGH SPECIFIC ACTIVITIES; RADIOCHEMICAL YIELD; SINGLE SPECIES; SPECIFIC YIELD; SYNTHESISED;

PATHOLOGY;

BISPHOSPHONIC ACID DERIVATIVE; DIPICOLYLAMINE ALENDRONATE RE 188; ETIDRONIC ACID RE 186; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; ALENDRONIC ACID; ANTINEOPLASTIC AGENT; RADIOISOTOPE; RHENIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE METABOLISM; BONE METASTASIS; CLINICAL EVALUATION; CONJUGATE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG ACCUMULATION; DRUG SYNTHESIS; DRUG TARGETING; FEMALE; IMAGING; IN VIVO STUDY; MOUSE; NONHUMAN; PALLIATIVE THERAPY; RADIOCHEMISTRY; ANIMAL; BAGG ALBINO MOUSE; BONE TUMOR; CHEMISTRY; HUMAN; METASTASIS; SYNTHESIS;

ALENDRONATE; ANIMALS; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; DIPHOSPHONATES; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; RADIOISOTOPES; RADIOPHARMACEUTICALS; RHENIUM;

EID: 77952576745     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc100071k     Document Type: Article

References (24)

1. Jasmin, C. (2005) Textbook of bone metastases, J. Wiley & Sons, Hoboken, NJ.
2. Lewington, V. J. (2005) Bone-seeking radionuclides for therapy J. Nucl. Med. 46, 38s-47s
3. Lewington, V. J., McEwan, A. J., Ackery, D. M., Bayly, R. J., Keeling, D. H., Macleod, P. M., Porter, A. T., and Zivanovic, M. A. (1991) A prospective, randomized double-blind crossover study to examine the efficacy of Sr-89 in pain palliation in patients with advanced prostate-cancer metastatic to bone Eur. J. Cancer 27, 954-958
4. Resche, I., Chatal, J. F., Pecking, A., Ell, P., Duchesne, G., Rubens, R., Fogelman, I., Houston, S., Fauser, A., Fischer, M., and Wilkins, D. (1997) A dose-controlled study of Sm-153-ethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastases Eur. J. Cancer 33, 1583-1591
5. Tian, J. H., Zhang, J. M., Hou, Q. T., Oyang, Q. H., Wang, J. M., Luan, Z. S., Chuan, L., and He, Y. J. (1999) Multicentre trial on the efficacy and toxicity of single-dose samarium-153-ethylene diamine tetramethylene phosphonate as a palliative treatment for painful skeletal metastases in China Eur. J. Nucl. Med. 26, 2-7
6. Krishnamurthy, G. T. and Krishnamurthy, S. (2000) Invited commentary-Radionuclides for metastatic bone pain palliation: A need for rational re-evaluation in the new millennium J. Nucl. Med. 41, 688-691
7. Blower, P. J., Kettle, A. G., ODoherty, M. J., Coakley, A. J., and Knapp, F. F. (2000) Tc-99m(V)DMSA quantitatively predicts Re-188(V)DMSA distribution in patients with prostate cancer metastatic to bone Eur. J. Nucl. Med. 27, 1405-1409
8. Blower, P. J., Lam, A. S. K., ODoherty, M. J., Kettle, A. G., Coakley, A. J., and Knapp, F. F. (1998) Pentavalent rhenium-188 dimercaptosuccinic acid for targeted radiotherapy: synthesis and preliminary animal and human studies Eur. J. Nucl. Med. 25, 613-621
9. Tian, M., Zhang, H., Li, S., Endo, K., and Tanada, S. (2004) Rhenium-188-HEDP for the palliation of painful bone metastases J. Clin. Oncol. 22, 766S-766S
10. Liepe, K., Kropp, J., Runge, R., and Kotzerke, J. (2003) Therapeutic efficiency of rhenium-188-HEDP in human prostate cancer skeletal metastases Br. J. Cancer 89, 625-629 (Pubitemid 37076163)
11. Palmedo, H., Grunwald, F., Wagner, U., Kohler, S., Krebs, D., and Biersack, H. J. (1998) Remission of bone metastases after combined chemotherapy and radionuclide therapy with Re-186-HEDP Clin. Nucl. Med. 23, 501-504
12. de Klerk, J. M. H., van het Schip, A. D., Zonnenberg, B. A., van Dijk, A., Quirijnen, J., Blijham, G. H., and van Rijk, P. P. (1996) Phase I study of rhenium-186-HEDP in patients with bone metastases originating from breast cancer J. Nucl. Med. 37, 244-249
13. Maxon, H. R., Schroder, L. E., Hertzberg, V. S., Thomas, S. R., Englaro, E. E., Samaratunga, R., Smith, H., Moulton, J. S., Williams, C. C., Ehrhardt, G. J., and Schneider, H. J. (1991) Rhenium-186(Sn)HEDP for treatment of painful osseous metastases-results of a double-blind crossover comparison with placebo J. Nucl. Med. 32, 1877-1881
14. Palmedo, H., Guhlke, S., Bender, H., Sartor, J., Schoeneich, G., Risse, J., Grunwald, F., Knapp, F. F., and Biersack, H. J. (2000) Dose escalation study with rhenium-188 hydroxyethylidene diphosphonate in prostate cancer patients with osseous metastases Eur. J. Nucl. Med. 27, 123-130
15. Handeland, ., Lindegaard, M. W., and Heggli, D.-E. (1989) Biodistribution of anionic separated MDP complexes from different MDP preparations Eur. J. Nucl. Med. Mol. Imaging 15, 609-611
16. de Klerk, J. M. H., van Dijk, A., van het Schip, A. D., Zonnenberg, B. A., and van Rijk, P. P. (1992) Pharmacokinetics of 186Re after administration of 186Re-HEDP to patients with bone metastases J. Nucl. Med. 33, 646-651
17. Hsieh, B. T., Hsieh, J. F., Tsai, S. C., Lin, W. Y., Wang, S. J., and Ting, G. (1999) Comparison of various rhenium-188-labeled diphosphonates for the treatment of bone metastases Nucl. Med. Biol. 26, 973-976
18. 3-conjugated bisphosphonate for the palliation of metastatic bone pain based on the concept of bifunctional radiopharmaceuticals Bioconjugate Chem. 16, 751-757
19. El-Mabhouh, A., Angelov, C., McEwan, A., Jia, G., and Mercer, J. (2004) Preclinical investigations of drug and radionuclide conjugates of bisphosphonates for the treatment of metastatic bone cancer Cancer Biother. Radiopharm. 19, 627-640
20. Ogawa, K., Mukai, T., Arano, Y., Otaka, A., Ueda, M., Uehara, T., Magata, Y., Hashimoto, K., and Saji, H. (2006) Rhenium-186-monoaminemonoamidedithiol- conjugated bisphosphonate derivatives for bone pain palliation Nucl. Med. Biol. 33, 513-520
21. Torres Martin de Rosales, R., Finucane, C., Mather, S. J., and Blower, P. J. (2009) Bifunctional bisphosphonate complexes for the diagnosis and therapy of bone metastases Chem. Commun. 4847-4849
22. + and synthesis of tailor-made bifunctional ligand systems Bioconjugate Chem. 13, 750-756
23. Riese, C., Seitz, S., Schipper, M., and Behr, T. (2009) Effective treatment of pancreatic neuroendocrine tumours transfected with the sodium iodide symporter gene by 186Re-perrhenate in mice Eur. J. Nucl. Med. Mol. Imaging 36, 1767-1773
24. Waibel, R., Alberto, R., Willuda, J., Finnern, R., Schibli, R., Stichelberger, A., Egli, A., Abram, U., Mach, J. P., Pluckthun, A., and Schubiger, P. A. (1999) Stable one-step technetium-99m labeling of His-tagged recombinant proteins with a novel Tc(I)-carbonyl complex Nat. Biotechnol. 17, 897-901